Atlas Trials

Pembrolizumab in Early Stage Colon Cancer

Clinical trial NCT04231526 · WITHDRAWN

Trial details

NCT number
NCT04231526
Sponsor
University of Chicago
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Colon Cancer
Start date
2020-05-20
Primary completion
2022-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.